About Seevix
Seevix is a company based in Jerusalem (Israel) founded in 2014. Seevix offers products and services including SVX, SpheroSeev, and HydroSeev. Seevix operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Jerusalem, Israel
-
Sectors
HealthcareChemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Seevix
Seevix offers a comprehensive portfolio of products and services, including SVX, SpheroSeev, and HydroSeev.
Biopolymer inspired by spidersilk to enhance product strength and sustainability.
Tool for improving 3D cell culture applications in biotechnology.
System that enhances 3D cell culture for medical and research uses.
People of Seevix
Unlock access to complete
Leadership Team
2 people
Private Team
1 people
Co Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Seevix
Investors in Seevix
Seevix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and ASICS Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brand of sportswear
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Seevix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seevix
Investment portfolio details for Seevix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Seevix
Detailed financials for Seevix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seevix Comparisons
Peer comparison for Seevix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seevix
Seevix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Seevix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seevix
Complete news archive for Seevix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seevix
Seevix was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Seevix is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Seevix was established in 2014 in Jerusalem, Israel, within the biotechnology and materials sector. Patented genetic engineering techniques are applied to create spider silk fibers that match natural counterparts. These fibers function as substitutes for Kevlar and steel in high-tensile roles. A proprietary one-step manufacturing process is utilized for scalable production, which shortens timelines and lowers expenses. Operations focus on supplying materials to diverse industries.
Seevix's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Seevix offers SVX, SpheroSeev, and HydroSeev.
Seevix has 2 investors. Key investors include European Union, and ASICS Corporation.